FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:379 January 30, 1997 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Javaheri et al. (Aug. 22 issue)¹ report that short-term treatment with theophylline for periodic breathing in patients with cardiac failure reduces the number of episodes of apnea and the duration of arterial hypoxemia during sleep. Although these results are encouraging, an important concern regarding the use of theophylline in this group of patients is the possibility of an increase in the risk of cardiac arrhythmias. After five days of treatment, Holter monitoring failed to detect any increase in ventricular arrhythmias while the patients were taking theophylline. However, several studies have clearly demonstrated the proarrhythmic side effects of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bakst, A. E., Gaine, S. P., Rubin, L. J. (1999). Continuous Intravenous Epoprostenol Therapy for Pulmonary Hypertension in Gaucher's Disease. Chest 116: 1127-1129 [Abstract] [Full Text]